José Ballester Beltrán (Jose Ballester-Beltrán, Jose Ballester-Beltran)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

High Throughput

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaojuan Zhao, Dominic Alibhai, Tony G Walsh, Nathalie Tarassova, Maximilian Englert, Semra Z Birol, Yong Li, Christopher M Williams, Chris R Neal, Philipp Burkard, Stephen J Cross, Elizabeth W Aitken, Amie K Waller, José Ballester Beltrán, Peter W Gunning, Edna C Hardeman, Ejaife Ono Agbani, Bernhard Nieswandt, Ingeborg Hers, Cedric Ghevaert, Alastair W Poole
Highly efficient platelet generation in lung vasculature reproduced by microfluidics. Nature communications 14 (1) (2023)
Georgina S F Anderson, José Ballester Beltrán, George Giotopoulos, Jose A Guerrero, Sylvanie Surget, James C Williamson, Tsz So, David Bloxham, Anna Aubareda, Ryan J Asby, Ieuan Walker, Lesley Jenkinson, Elizabeth J Soilleux, James P Roy, Ana Teodosio, Catherine Ficken, Leah Officer, Sara Nasser, Sheri Skerget, Jonathan J Keats, Peter Greaves, Yu-Tzu Tai, Kenneth C Anderson, Marion MacFarlane, James E D Thaventhiran, Brian James Patrick Huntly, Paul J Lehner, Michael A Chapman
Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma. Blood 139 (16) (2022)
Cavan Bennett, Moyra Lawrence, Jose A Guerrero, Simon Stritt, Amie K Waller, Yahui Yan, Richard W Mifsud, José Ballester Beltrán, Ayesha Baig, Annett Mueller, Louisa Mayer, James Warland, Christopher J Penkett, Parsa Akbari, Thomas Moreau, Amanda L Evans, Souradip Mookerjee, Gary J Hoffman, Kourosh Saeb Parsy, David J Adams, Amber L Couzens, Markus Bender, Wendy N Erber, Bernhard Nieswandt, Randy J Read, Cedric Ghevaert
CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemia. Blood 139 (14) (2022)